Complete remission in metastatic primary malignant melanoma of the esophagus with nivolumab: a case report.

Immune checkpoint inhibitors may have astonishing curative effects in selected populations. More research is warranted to identify factors that increase the likelihood of achieving complete remission in primary malignant melanoma of the esophagus as well as in other melanomas.